Chicago Partners Investment Group LLC Curis Inc Transaction History

Chicago Partners Investment Group LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$4.45 - $8.09 $44,807 - $81,458	-10,069 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$6.94 - $8.85 $69,878 - $89,110	10,069 New	10,069 $78,000
Q2 2021 Aug 02, 2021	SELL	$7.45 - $16.27 $76,578 - $167,239	-10,279 Closed	0 $0
Q1 2021 Apr 28, 2021	BUY	$8.78 - $12.8 $90,249 - $131,571	10,279 New	10,279 $110,000
Q4 2018 Jan 11, 2019	SELL	$0.62 - $2.25 $12 - $45	-20 Closed	0 $0
Q2 2018 Aug 31, 2018	BUY	$1.73 - $3.35 $34 - $67	20 New	20 $0

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $393M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Chicago Partners Investment Group LLC, based on Form 13F filings with the SEC.

Stay updated on Chicago Partners Investment Group LLC with notifications on news.